Pregnant women of high hemoglobin. Abnormal haematological finding on antenatal screening of mother
Conditions
Interventions
Intervention 1: Ferrous sulfate, 150 mg tablet with 50 mg ferrous elemental, daily, from 20th gestational week to the end of pregnancy. Intervention 2: Placebo tablets, one tablet daily, from 20th ges
Prevention
Ferrous sulfate, 150 mg tablet with 50 mg ferrous elemental, daily, from 20th gestational week to the end of pregnancy
Placebo tablets, one tablet daily, from 20th gestational week to the end of pregnancy
Sponsors
Tarbiat Modarres University
Eligibility
Sex/Gender
Female
Age
17 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Pregnant women with Hb = 13.2 g/dl in the early stage of the second trimester, body mass index (BMI) between 19.8 and 26 kg/m2, single pregnancy, age between 17 and 35 years Exclusion criteria: Falling Hb to less than 10.5 g/dl in the second trimester or 11 g/dl in the third trimester, history of any renal, hepatic, thyroid, or cardiac diseases, presence of diabetes, asthma, hypertension, or inflammatory diseases, presence of severe nausea and vomiting of pregnancy, smoking, substance abuse, history of threatened abortion
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic indices. Timepoint: Baseline, at gestational weeks 24 -28 and 32-36. Method of measurement: Cell Blood Count with sismex k1000. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Hamzehgardeshi
Tarbiat Modarres University,Tehran University medical science
Outcome results
None listed